MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT

NCT02931929 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: 68Ga-NeoBOMB1, 2-vial kit

Sponsor

Medical University Innsbruck

Collaborators

[object Object]